RT @BromageDan: @_antocannata @HanCardiomd @hvanspall @escardio @corneliacrm @ARakisheva An interesting question on the use of ACEi in myoc…
@_antocannata @HanCardiomd @hvanspall @escardio @corneliacrm @ARakisheva An interesting question on the use of ACEi in myocarditis with preserved EF. No evidence from humans (yet) but some signal in preclinical studies 👇🦠🫀 https://t.co/VTUJUlKuhb
RT @AngoulvantD: Meta analysis of studies investigating drugs beneficial effects in in vivo models of #myocarditis. A first step before fut…
RT @AngoulvantD: Meta analysis of studies investigating drugs beneficial effects in in vivo models of #myocarditis. A first step before fut…
RT @AngoulvantD: Meta analysis of studies investigating drugs beneficial effects in in vivo models of #myocarditis. A first step before fut…
RT @AngoulvantD: Meta analysis of studies investigating drugs beneficial effects in in vivo models of #myocarditis. A first step before fut…
RT @AngoulvantD: Meta analysis of studies investigating drugs beneficial effects in in vivo models of #myocarditis. A first step before fut…
RT @AngoulvantD: Meta analysis of studies investigating drugs beneficial effects in in vivo models of #myocarditis. A first step before fut…
Meta analysis of studies investigating drugs beneficial effects in in vivo models of #myocarditis. A first step before future RCT in patients to establish robust level of evidence in future guidelines @SABOURETCardio @AtulPathak31 @FZores https://t.co/UFS0